Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4+ T cells in vitro.

Nunes JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, Diaz RS, Janini LMR.

Virology. 2018 Oct;523:41-51. doi: 10.1016/j.virol.2018.07.026. Epub 2018 Aug 2.

PMID:
30077875
2.

Immune Activation, Proinflammatory Cytokines, and Conventional Risks for Cardiovascular Disease in HIV Patients: A Case-Control Study in Bahia, Brazil.

Brites-Alves C, Luz E, Netto EM, Ferreira T, Diaz RS, Pedroso C, Page K, Brites C.

Front Immunol. 2018 Jun 26;9:1469. doi: 10.3389/fimmu.2018.01469. eCollection 2018.

3.

Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression.

Leda AR, Hunter J, Oliveira UC, Azevedo IJ, Sucupira MCA, Diaz RS.

J Antimicrob Chemother. 2018 Apr 19. doi: 10.1093/jac/dky132. [Epub ahead of print]

PMID:
29684141
4.

Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals.

Arruda MB, Boullosa LT, Cardoso CC, da Costa CM, Alves CR, de Lima ST, Kaminski HT, Aleixo AW, Esposito AO, Cavalcanti AM, Riedel M, Couto-Fernandez JC, Ferreira SB, de Oliveira IC, Portal LE, Wolf HH, Fernandes SB, de M C Pardini MI, Feiteiro MV, Tolentino FM, Diaz RS, Lopes GI, Francisco RB, Véras NM, Pires AF, Franchini M, Mesquita F, Tanuri A; HIV-BResNet.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25032.

5.

Impact of antiretroviral resistance and virological failure on HIV-1 informational entropy.

Lima ENC, Piqueira JRC, Camargo M, Galinskas J, Sucupira MC, Diaz RS.

J Antimicrob Chemother. 2018 Apr 1;73(4):1054-1059. doi: 10.1093/jac/dkx508.

PMID:
29373694
6.

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety.

Vergara TRC, Samer S, Santos-Oliveira JR, Giron LB, Arif MS, Silva-Freitas ML, Cherman LA, Treitsman MS, Chebabo A, Sucupira MCA, Da-Cruz AM, Diaz RS; SPARC Working Group.

EBioMedicine. 2017 Sep;23:59-67. doi: 10.1016/j.ebiom.2017.08.007. Epub 2017 Aug 12.

7.

Late Presentation HIV/AIDS Is Still a Challenge in Brazil and Worldwide.

Komninakis SV, Mota ML, Hunter JR, Diaz RS.

AIDS Res Hum Retroviruses. 2018 Feb;34(2):129-131. doi: 10.1089/AID.2015.0379. Epub 2017 Sep 21.

PMID:
28797184
8.

Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Arif MS, Hunter J, Léda AR, Zukurov JPL, Samer S, Camargo M, Galinskas J, Kallás EG, Komninakis SV, Janini LM, Sucupira MC, Diaz RS.

J Virol. 2017 Sep 12;91(19). pii: e00793-17. doi: 10.1128/JVI.00793-17. Print 2017 Oct 1.

9.

Evidence of Noncompetent HIV after Ex Vivo Purging Among ART-Suppressed Individuals.

Samer S, Namiyama G, Oshiro T, Arif MS, Cardoso da Silva W, Sucupira MCA, Janini LM, Diaz RS.

AIDS Res Hum Retroviruses. 2017 Oct;33(10):993-994. doi: 10.1089/aid.2017.0036. Epub 2017 Jun 20. No abstract available.

PMID:
28632400
10.

Genetic Diversity of HIV-1 Gene vif Among Treatment-Naive Brazilians.

Villanova F, Barreiros M, Janini LM, Diaz RS, Leal É.

AIDS Res Hum Retroviruses. 2017 Sep;33(9):952-959. doi: 10.1089/AID.2016.0230. Epub 2017 May 24.

PMID:
28443724
11.

Uniquely altered transcripts are associated with immune preservation in HIV infection.

Zanoni M, Aventurato ÍK, Hunter J, Sucupira MC, Diaz RS.

PLoS One. 2017 Mar 28;12(3):e0169868. doi: 10.1371/journal.pone.0169868. eCollection 2017.

12.

Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.

Scarpellini B, Zanoni M, Sucupira MC, Truong HM, Janini LM, da Silva ID, Diaz RS.

PLoS One. 2017 Feb 24;12(2):e0173164. doi: 10.1371/journal.pone.0173164. eCollection 2017.

13.

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.

Scarpellini B, Zanoni M, Sucupira MC, Truong HM, Janini LM, Segurado ID, Diaz RS.

PLoS One. 2016 Dec 12;11(12):e0161920. doi: 10.1371/journal.pone.0161920. eCollection 2016. Erratum in: PLoS One. 2017 Feb 24;12 (2):e0173164. Scarpelini, Bruno [corrected to Scapellini, Bruno].

14.

Identification of a new hepatitis B virus recombinant D2/D3 in the city of São Paulo, Brazil.

Santana LC, Mantovani NP, Ferreira MC, Arnold R, Duro RL, Ferreira PR, Hunter JR, Leal É, Diaz RS, Komninakis SV.

Arch Virol. 2017 Feb;162(2):457-467. doi: 10.1007/s00705-016-3122-2. Epub 2016 Oct 27.

PMID:
27787680
15.

Is Hepatitis Delta infections important in Brazil?

Cicero MF, Pena NM, Santana LC, Arnold R, Azevedo RG, Leal ÉS, Diaz RS, Komninakis SV.

BMC Infect Dis. 2016 Sep 29;16(1):525.

16.

Efficient Identification of HIV Serodiscordant Couples by Existing HIV Testing Programs in South Brazil.

Pilcher CD, Bisol CA, Paganella MP, Vallabhaneni S, da Motta LR, Kato SK, Sperhacke RD, Kallas EG, Hecht FM, Diaz RS.

PLoS One. 2015 Nov 12;10(11):e0142638. doi: 10.1371/journal.pone.0142638. eCollection 2015.

17.

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use.

Diaz RS, Inocêncio LA, Sucupira MC, Pereira AA, Hunter J, Ferreira JE, Araújo LV, Souza DF, Sabino EC.

PLoS One. 2015 Oct 28;10(10):e0139677. doi: 10.1371/journal.pone.0139677. eCollection 2015.

18.

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil.

Grinberg G, Giron LB, Knoll RK, Galinskas J, Camargo M, Arif MS, Samer S, Janini LM, Sucupira MC, Diaz RS.

Braz J Infect Dis. 2015 Nov-Dec;19(6):631-5. doi: 10.1016/j.bjid.2015.08.001. Epub 2015 Sep 9.

19.

Epigenetic modulations in activated cells early after HIV-1 infection and their possible functional consequences.

Maricato JT, Furtado MN, Takenaka MC, Nunes ER, Fincatti P, Meliso FM, da Silva ID, Jasiulionis MG, Cecília de Araripe Sucupira M, Diaz RS, Janini LM.

PLoS One. 2015 Apr 13;10(4):e0119234. doi: 10.1371/journal.pone.0119234. eCollection 2015.

20.

Data-intensive analysis of HIV mutations.

Ozahata MC, Sabino EC, Diaz RS, Cesar RM Jr, Ferreira JE.

BMC Bioinformatics. 2015 Feb 5;16:35. doi: 10.1186/s12859-015-0452-0.

21.

Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots.

de Moraes Soares CM, Vergara TR, Brites C, Brito JD, Grinberg G, Caseiro MM, Correa C, Suffert TA, Pereira FR, Camargo M, Janini LM, Komninakis S, Sucupira MC, Diaz RS.

J Int AIDS Soc. 2014 Sep 22;17:19042. doi: 10.7448/IAS.17.1.19042. eCollection 2014.

22.

In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.

de Lima-Stein ML, Alkmim WT, Bizinoto MC, Lopez LF, Burattini MN, Maricato JT, Giron L, Sucupira MC, Diaz RS, Janini LM.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):867-80. doi: 10.1089/AID.2013.0241. Epub 2014 Aug 25.

23.

High rates of human immunodeficiency virus type 1 mutational profiles by single-genome amplification after 48-hour propagation in peripheral blood mononuclear cells at different levels of cell activation.

Russo CT, Alkmim W, Munerato P, Zukurov J, Maricato JT, Sucupira MC, Diaz RS, Janini LM.

Intervirology. 2014;57(5):277-88. doi: 10.1159/000362415. Epub 2014 Jun 28.

24.

KIR and a specific HLA-C gene are associated with susceptibility and resistance to hepatitis B virus infection in a Brazilian population.

Araujo P, Gonçalves G, Latini F, Ferreira O, Porto LC, Barreto JA, Girao MJ, Diaz RS.

Cell Mol Immunol. 2014 Nov;11(6):609-12. doi: 10.1038/cmi.2014.29. Epub 2014 May 19. No abstract available.

25.

Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil.

Salustiano DM, Lima KO, Cavalcanti AM, Diaz RS, Lacerda HR.

Braz J Infect Dis. 2014 Jul-Aug;18(4):449-53. doi: 10.1016/j.bjid.2014.03.001. Epub 2014 Apr 26.

26.

Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission.

Gouveia NL, Camargo M, Caseiro MM, Janini LM, Sucupira MC, Diaz RS.

Virus Genes. 2014 Jun;48(3):421-8. doi: 10.1007/s11262-014-1048-x. Epub 2014 Feb 14.

PMID:
24526349
27.

Analysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, Brazil.

Nunes ER, Zukurov JP, Maricato JT, Sucupira MC, Diaz RS, Janini LM.

PLoS One. 2014 Jan 3;9(1):e84066. doi: 10.1371/journal.pone.0084066. eCollection 2014.

28.

Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.

Mantovani N, Cicero M, Santana LC, Silveira C, do Carmo EP, Abrão PR, Diaz RS, Caseiro MM, Komninakis SV.

Virol J. 2013 Oct 28;10:320. doi: 10.1186/1743-422X-10-320.

29.

Short communication: HIV type 1 tropism determination in a novel dried blood spot membrane and the use of a mixture of outer nested polymerase chain reaction primers.

Lavigne S, Santos C, Arif MS, Reis A, Samer S, Dos Santos CV, Diaz RS.

AIDS Res Hum Retroviruses. 2014 Feb;30(2):147-50. doi: 10.1089/AID.2012.0261. Epub 2013 Nov 8.

PMID:
24111560
30.

Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B.

Tarosso LF, Sanabani SS, Ribeiro SP, Sauer MM, Tomiyama HI, Sucupira MC, Diaz RS, Sabino EC, Kalil J, Kallas EG.

AIDS Res Hum Retroviruses. 2014 Feb;30(2):190-4. doi: 10.1089/AID.2012.0243. Epub 2013 Sep 6.

PMID:
23906381
31.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S; extended SAILING Study Team.

Lancet. 2013 Aug 24;382(9893):700-8. doi: 10.1016/S0140-6736(13)61221-0. Epub 2013 Jul 3. Erratum in: Lancet. 2014 Jan 4;383(9911):30.

PMID:
23830355
32.

Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count.

Bizinoto MC, Yabe S, Leal É, Kishino H, Martins Lde O, de Lima ML, Morais ER, Diaz RS, Janini LM.

BMC Infect Dis. 2013 Apr 11;13:173. doi: 10.1186/1471-2334-13-173.

33.

The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).

Cahn P, Ruxrungtham K, Gazzard B, Diaz RS, Gori A, Kotler DP, Vriesema A, Georgiou NA, Garssen J, Clerici M, Lange JM; (BTE) Blinded Nutritional Study for Immunity and Tolerance Evaluation Study Team.

Clin Infect Dis. 2013 Jul;57(1):139-46. doi: 10.1093/cid/cit171. Epub 2013 Mar 19.

PMID:
23511299
34.

Phenotypic susceptibility to antiretrovirals among clades C, F, and B/F recombinant antiretroviral-naive HIV type 1 strains.

Sucupira MC, Munerato P, Silveira J, Santos AF, Janini LM, Soares MA, Diaz RS.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):880-6. doi: 10.1089/AID.2012.0259. Epub 2013 Mar 8.

PMID:
23398474
35.

Intermediate levels of transmitted antiretroviral drug resistance in Midwestern Brazil.

Pfrimer IA, Bizinoto MC, Brandão NA, Camargo M, Sucupira MC, Janini LM, Diaz RS.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):205-6. doi: 10.1089/AID.2012.0012. Epub 2012 Oct 9. No abstract available.

PMID:
22978276
36.

Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell counts.

Leal É, Casseb J, Hendry M, Busch MP, Diaz RS.

PLoS One. 2012;7(6):e39776. doi: 10.1371/journal.pone.0039776. Epub 2012 Jun 29.

37.

Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco.

Cavalcanti AM, Brito AM, Salustiano DM, Lima KO, Silva SP, Diaz RS, Lacerda HR.

Mem Inst Oswaldo Cruz. 2012 Jun;107(4):450-7.

38.

Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: final results of two randomized phase III trials.

Caseiro MM, Nelson M, Diaz RS, Gathe J, de Andrade Neto JL, Slim J, Solano A, Netto EM, Mak C, Shen J, Greaves W, Dunkle LM, Vilchez RA, Zeinecker J.

J Infect. 2012 Oct;65(4):326-35. doi: 10.1016/j.jinf.2012.05.008. Epub 2012 May 24.

PMID:
22634184
39.

HIV-1 proviral DNA loads (as determined by quantitative PCR) in patients subjected to structured treatment interruption after antiretroviral therapy failure.

Komninakis SV, Santos DE, Santos C, Oliveros MP, Sanabani S, Diaz RS.

J Clin Microbiol. 2012 Jun;50(6):2132-3. doi: 10.1128/JCM.00393-12. Epub 2012 Mar 14.

40.

Incidence of recent human immunodeficiency virus infection at two voluntary counseling testing centers in Pernambuco, Brazil, from 2006 to 2009.

de Lima KO, Salustiano DM, Coêlho MR, Cavalcanti AM, Diaz RS, Lacerda HR.

J Clin Microbiol. 2012 Jun;50(6):2145-6. doi: 10.1128/JCM.05107-11. Epub 2012 Mar 7.

41.

Analysis of transmitted resistance to raltegravir and selective pressure among HIV-1-infected patients on a failing HAART in Sao Paulo, Brazil.

Mantovani NP, Azevedo RG, Rabelato JT, Sanabani S, Diaz RS, Komninakis SV.

J Clin Microbiol. 2012 Jun;50(6):2122-5. doi: 10.1128/JCM.00539-12. Epub 2012 Mar 7.

42.

Effect of natural polymorphisms in the HIV-1 CRF02_AG protease on protease inhibitor hypersusceptibility.

Santos AF, Tebit DM, Lalonde MS, Abecasis AB, Ratcliff A, Camacho RJ, Diaz RS, Herchenröder O, Soares MA, Arts EJ.

Antimicrob Agents Chemother. 2012 May;56(5):2719-25. doi: 10.1128/AAC.06079-11. Epub 2012 Feb 13.

43.

Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains.

Sucupira MC, Sanabani S, Cortes RM, Giret MT, Tomiyama H, Sauer MM, Sabino EC, Janini LM, Kallas EG, Diaz RS.

PLoS One. 2012;7(1):e30292. doi: 10.1371/journal.pone.0030292. Epub 2012 Jan 26.

44.

Short communication: Evaluation of GB virus C/hepatitis G viral load among HIV type 1-coinfected patients in São Paulo, Brazil.

Alves-Sousa VK, Komninakis SC, Baggio-Zappia GL, Barbosa AJ, Mantovani NP, Diaz RS, Abrão P, Lanzara GA, Granato CF.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1301-4. Epub 2012 Mar 23.

PMID:
22242901
45.

Decrease in lipoatrophy in a pilot study using a short-term treatment interruption strategy for 48 weeks in São Paulo, Brazil.

Gosuen GC, Turcato G Jr, Salomao R, Lewi DS, Diaz RS.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):747-8. doi: 10.1089/AID.2011.0292. Epub 2012 Mar 23. No abstract available.

PMID:
22220684
46.

Association between IL28B gene polymorphisms and sustained virological response in patients coinfected with HCV and HIV in Brazil.

Ferreira PR, Santos C, Côrtes R, Reis A, Tenore Sde B, Silva MH, Vilhena C, Diaz RS.

J Antimicrob Chemother. 2012 Feb;67(2):509-10. doi: 10.1093/jac/dkr488. Epub 2011 Dec 6. No abstract available.

PMID:
22146876
47.

Comparative effectiveness of dried-plasma hepatitis B virus viral load (VL) testing in three different VL commercial platforms using ViveST for sample collection.

Zanoni M, Giron LB, Vilhena C, Sucupira MC, Lloyd RM Jr, Diaz RS.

J Clin Microbiol. 2012 Jan;50(1):145-7. doi: 10.1128/JCM.01016-11. Epub 2011 Oct 19.

48.

Prevalence and factors associated with HSV-2 and hepatitis B infections among truck drivers crossing the southern Brazilian border.

Pinho AA, Chinaglia M, Lippman SA, Reingold A, Diaz RS, Sucupira MC, Page K, Díaz J.

Sex Transm Infect. 2011 Dec;87(7):553-9. doi: 10.1136/sextrans-2011-050186. Epub 2011 Oct 3.

49.

The Brazilian network for HIV-1 genotyping external quality control assurance programme.

Souza DC, Sucupira MC, Brindeiro RM, Fernandez JC, Sabino EC, Inocencio LA, Diaz RS.

J Int AIDS Soc. 2011 Sep 21;14:45. doi: 10.1186/1758-2652-14-45.

50.

The use of real-time PCR to detect hepatitis C virus RNA in dried blood spots from Brazilian patients infected chronically.

Santos C, Reis A, Dos Santos CV, Damas C, Silva MH, Viana MV, Ferraz ML, Carnauba D, El-Far F, Serra F, Diaz RS.

J Virol Methods. 2012 Jan;179(1):17-20. doi: 10.1016/j.jviromet.2011.06.012. Epub 2011 Jun 24.

PMID:
21871496

Supplemental Content

Loading ...
Support Center